Cervical cancer: an overview of pathophysiology and management

CA Johnson, D James, A Marzan, M Armaos - Seminars in oncology …, 2019 - Elsevier
Objective To provide an overview of the etiology, prevention, diagnosis, treatment, and long-
term survivorship concerns surrounding cervical cancer. Data Sources A review of articles …

Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation …

SJ Bowden, T Doulgeraki, E Bouras, G Markozannes… - BMC medicine, 2023 - Springer
Background Persistent infection by oncogenic human papillomavirus (HPV) is necessary
although not sufficient for development of cervical cancer. Behavioural, environmental, or …

[HTML][HTML] Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

M Arbyn, E Weiderpass, L Bruni… - The Lancet Global …, 2020 - thelancet.com
Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

[HTML][HTML] HPV vaccination and the risk of invasive cervical cancer

J Lei, A Ploner, KM Elfström, J Wang… - … England Journal of …, 2020 - Mass Medical Soc
Background The efficacy and effectiveness of the quadrivalent human papillomavirus (HPV)
vaccine in preventing high-grade cervical lesions have been shown. However, data to …

Trends in human papillomavirus–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017

CI Liao, AA Francoeur, DS Kapp, MAP Caesar… - JAMA network …, 2022 - jamanetwork.com
Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …

Cervicovaginal microbiome and natural history of HPV in a longitudinal study

M Usyk, CP Zolnik, PE Castle, C Porras… - PLoS …, 2020 - journals.plos.org
Background Human papillomavirus (HPV) infection is one of the most common sexually
transmitted infections. However, only a small percentage of high-risk (HR) HPV infections …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

[HTML][HTML] Worldwide burden of cervical cancer in 2008

M Arbyn, X Castellsagué, S de Sanjosé, L Bruni… - Annals of oncology, 2011 - Elsevier
Background The knowledge that persistent human papillomavirus infection is the main
cause of cervical cancer has resulted in the development of assays that detect nucleic acids …

Does the vaginal microbiota play a role in the development of cervical cancer?

M Kyrgiou, A Mitra, AB Moscicki - Translational Research, 2017 - Elsevier
Persistent infection with oncogenic human papillomavirus (HPV) is necessary but not
sufficient for the development of cervical cancer. The factors promoting persistence as well …

[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021

KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …